Área 4. Neurociencias y Órganos de los Sentidos
OBJETIVOS CIENTÍFICOS VINCULADOS AL PLAN ESTRATÉGICO
- Generar conocimiento científico de excelencia: el Área 4 ha mejorado su producción científica, consiguiendo los mejores números de la serie histórica en liderazgo. Además, ha aumentado significativamente el liderazgo de sus publicaciones. Su compromiso con la ciencia abierta es notable teniendo más de un 93% de artículos en open access.
- Captación y formación de talento científico: tanto la captación de recursos humanos competitivos como la formación de investigadores y técnicos son dos objetivos principales del área. A pesar de la escasa financiación competitiva, gracias a la financiación privada se ha logrado incrementar levemente el personal de apoyo a la investigación. En el 2022 se han defendido 6 tesis doctorales en el área.
- Dinamizar la captación de recursos: la captación de recursos competitivos ha sido nula durante 2023. Sin embargo, se ha producido un incremento importante en los ingresos por investigación clínica.
- Personal
- Publicaciones
- Listado Publicaciones
- Ayudas de Investigación
- Investigación Clínica
- Tesis Doctorales
9
Grupos de Investigación
- OFTALMOLOGÍA EXPERIMENTAL (CONSOLIDADO)
- FARMACOLOGÍA CELULAR Y MOLECULAR (CONSOLIDADO)
- REGIONALIZACION CEREBRAL Y GENES DEL DESARROLLO (CONSOLIDADO)
- NEUROCIENCIA CLÍNICA Y EXPERIMENTAL (CONSOLIDADO)
- PSICOBIOLOGÍA Y NEUROBIOLOGÍA DEL COMPORTAMIENTO (CONSOLIDADO)
- ENVEJECIMIENTO CEREBRAL Y DEMENCIAS (EMERGENTE)
- NEUROINTERVENCIONISMO (EMERGENTE)
- OFTALMOLOGÍA CLÍNICA (CLÍNICO ASOCIADO)
- FARMACOLOGÍA CLÍNICA Y EXPERIMENTAL (EMERGENTE)
INDICADORES GENERALES
45
Nº Publicaciones
169.3
Impacto Total
3.76
Impacto Medio
| Tipo | Nº Pubs | FI total | FI Medio |
| Originales | 38 (84.44%) | 134.4 | 3.54 |
| Revisiones | 7 (15.56%) | 34.9 | 4.99 |
57.78
Q1%
15.56
D1%
0
FI >= 15
| Tipo | Nº Q1 | Nº D1 | Nº FI >= 15 |
| Originales | 23 | 5 | 0 |
| Revisiones | 3 | 2 | 0 |
INDICADORES DE LIDERAZGO
28
(62.0%)
Nº Publicaciones
105.2
Impacto Total
3.76
Impacto Medio
| Nº Pubs | FI total | FI Medio | |
| Mujer | 14 (50.0%) | 57.6 | 4.11 |
| Hombre | 14 (50.0%) | 47.6 | 3.4 |
60.71
Q1%
17.86
D1%
0
FI >= 15
| Nº Q1 | Nº D1 | Nº FI >= 15 | |
| Mujer | 11 | 3 | 0 |
| Hombre | 6 | 2 | 0 |
OTROS INDICADORES
17.07
HCP10% (2019-2023)
40.48
HCP10 Liderado% (2019-2023)
19.05
HCP10 Lid. Mujeres% (2019-2023)
1.3
Crown (2019-2023)
93.33
Open Access%
68.89
Col. International%
* Se muestran las 5 especies, los 10 genes y las 20 enfermedades más nombradas. Los valores están normalizados logarítmicamente en base al número de publicaciones.
INDICADORES EVOLUTIVOS
DESTACADAS
Madrid-Valero JJ*, Gregory AM.
Behaviour genetics and sleep: A narrative review of the last decade of quantitative and molecular genetic research in humans.
Sleep Medicine Reviews, 2023, 69, 101769, PMID: 36933344, FI: 11.2
Martin-Sanchez F*, Compan V, Penin-Franch A, ..., Pelegrin P.
ASC oligomer favors caspase-1CARD domain recruitment after intracellular potassium efflux.
Journal of Cell Biology, 2023, 222, PMID: 37402211, FI: 7.4
Franco-Garcia A*, Gomez-Murcia V, Fernandez-Gomez FJ, ..., Victoria Milanes M*, Nunez C*.
Morphine-withdrawal aversive memories and their extinction modulate H4K5 acetylation and Brd4 activation in the rat hippocampus and basolateral amygdala.
Biomedicine & Pharmacotherapy, 2023, 165, 115055, PMID: 37356373, FI: 6.9
Madrid-Valero JJ*, Matthews T, Barclay NL et al.
Problematic technology use and sleep quality in young adulthood: novel insights from a nationally representative twin study.
Sleep, 2023, 46, PMID: 37106487, FI: 5.3
Gonzalez-Riquelme MJ*, Lucas-Ruiz F*, Galindo-Romero C, ..., Agudo-Barriuso M*.
Comparative Analysis of Retinal Organotypic Cultures and In Vivo Axotomized Retinas.
International Journal of Molecular Sciences, 2023, 24, PMID: 36834893, FI: 4.9
LISTADO COMPLETO
Basavarajappa D, Galindo-Romero C, Gupta V et al.
Signalling pathways and cell death mechanisms in glaucoma: Insights into the molecular pathophysiology.
Molecular Aspects of Medicine, 2023, 94, 101216, PMID: 37856930, FI: 8.7
Lee B, Hoyle C, Wellens R, ..., Martin-Sanchez F et al.
Disruptions in endocytic traffic contribute to the activation of the NLRP3 inflammasome.
Science Signaling, 2023, 16, eabm7134, PMID: 36809026, FI: 6.7
Ward LJ, Laucyte-Cibulskiene A, Hernandez L et al. COLABORADORES: Pilote L, Norris CM, Raparelli V, ..., Herrero MT.
Coronary artery calcification and aortic valve calcification in patients with kidney failure: a sex-disaggregated study.
Biology of sex Differences, 2023, 14, 48, PMID: 37443048, FI: 4.9
Franco-Garcia A, Guerrero-Bautista R, Hidalgo JM, ..., Gomez-Murcia V*, ..., Nunez C*.
Dopamine D3 Receptor Modulates Akt/mTOR and ERK(1/2) Pathways Differently during the Reinstatement of Cocaine-Seeking Behavior Induced by Psychological versus Physiological Stress.
International Journal of Molecular Sciences, 2023, 24, PMID: 37446391, FI: 4.9
Diaz C, de la Torre MM, Rubenstein JLR, Puelles L*.
Dorsoventral Arrangement of Lateral Hypothalamus Populations in the Mouse Hypothalamus: a Prosomeric Genoarchitectonic Analysis.
Molecular Neurobiology, 2023, 60, 687-731, PMID: 36357614, FI: 4.6
Pinana C, Remollo S, Zamarro J et al.
Derivo embolization device for intracranial aneurysms: a Spanish multicenter retrospective study.
Journal of Neurointerventional Surgery, 2023, 15, 871-875, PMID: 35999049, FI: 4.5
Espinosa de Rueda M, Ballenilla Marco F, Garmendia Lopetegui E, ..., Parrilla G.
Thrombectomy aspiration post-market study in acute stroke with the Q aspiration catheter: the TAPAS study.
Journal of Neurointerventional Surgery, 2023, 15, 674-678, PMID: 35641183, FI: 4.5
Herrero MT*, Yuste JE, Cuenca-Bermejo L et al.
7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate.
Open Biology, 2023, 13, 220370, PMID: 37192671, FI: 4.5
Cuenca-Bermejo L, Prinetti A, Kublickiene K, ..., Herrero MT.
Fundamental neurochemistry review: Old brain stories - Influence of age and sex on the neurodegeneration-associated lipid changes.
Journal of Neurochemistry, 2023, 166, 427-452, PMID: 37161795, FI: 4.2
Nadal-Nicolas FM*, Galindo-Romero C*, Lucas-Ruiz F, ..., Vidal-Sanz M*, Agudo-Barriuso M*.
Pan-retinal ganglion cell markers in mice, rats, and rhesus macaques.
Zoological Research, 2023, 44, 226-248, PMID: 36594396, FI: 4.0
Zuniga MP, Badillo E, Abalos P, ..., Escudero E et al.
Antimicrobial susceptibility of Rhodococcus equi strains isolated from foals in Chile.
World Journal of Microbiology & Biotechnology, 2023, 39, 231, PMID: 37347336, FI: 4.0
Meca-Lallana JE, Prieto Gonzalez JM, Caminero Rodriguez AB et al.
Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.
Neurology and Therapy, 2023, 12, 2177-2193, PMID: 37861931, FI: 3.9
Azizi Z, Lindner S, Shiba Y, ..., Herrero MT et al.
A comparison of synthetic data generation and federated analysis for enabling international evaluations of cardiovascular health.
Scientific Reports, 2023, 13, 11540, PMID: 37460705, FI: 3.8
Rauf B, Sharpless BA, Denis D, ..., Madrid-Valero JJ et al.
Isolated sleep paralysis: Clinical features, perception of aetiology, prevention and disruption strategies in a large international sample.
Sleep Medicine, 2023, 104, 105-112, PMID: 36934464, FI: 3.8
De Araujo FM, Frota AF, de Jesus LB, ..., Cuenca-Bermejo L et al.
Aminochrome Induces Neuroinflammation and Dopaminergic Neuronal Loss: A New Preclinical Model to Find Anti-inflammatory and Neuroprotective Drugs for Parkinson's Disease.
Cellular and Molecular Neurobiology, 2023, 43, 265-281, PMID: 34988761, FI: 3.6
Calais-Ferreira L, Pozzobon D, Pinheiro MB, ..., Ordonana JR et al.
Sex differences in lifetime prevalence of low back pain: A multinational study of opposite-sex twin pairs.
European Journal of Pain, 2023, 10.1002/ejp.2146 [doi], PMID: 37357463, FI: 3.5
Garcia-Carmona JA, Garcia-Perez A, Isidro Garcia G et al.
Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study.
Therapeutic Advances in Psychopharmacology, 2023, 13, 20451253231220907, PMID: 38152569, FI: 3.4
Pavon-Pulido N, Blasco-Garcia JD, Lopez-Riquelme JA, ..., Herrero MT.
JUNO Project: Deployment and Validation of a Low-Cost Cloud-Based Robotic Platform for Reliable Smart Navigation and Natural Interaction with Humans in an Elderly Institution.
Sensors, 2023, 23, PMID: 36617079, FI: 3.4
Mandala C, Veronese N, Dominguez LJ, ..., Herrero MT et al.
Use of bioelectrical impedance analysis in centenarians: a systematic review.
Aging Clinical and Experimental Research, 2023, 35, 1-7, PMID: 36287324, FI: 3.4
Madrid-Valero JJ*, Kirkpatrick RM, Gonzalez-Javier F, ..., Ordonana JR*.
Sex differences in sleep quality and psychological distress: Insights from a middle-aged twin sample from Spain.
Journal of Sleep Research, 2023, 32, e13714, PMID: 36054078, FI: 3.4
Dueren AL, Bowling NC, Vafeiadou A, Madrid-Valero JJ et al.
Perspectives on interpersonal touch are related to subjective sleep quality.
Journal of Sleep Research, 2023, 32, e13766, PMID: 36351704, FI: 3.4
Rauf B, Perach R, Madrid-Valero JJ et al.
The associations between paranormal beliefs and sleep variables.
Journal of Sleep Research, 2023, 32, e13810, PMID: 36632033, FI: 3.4
Rauf B, Perach R, Madrid-Valero JJ et al.
Associations between sleep variables and ostensibly paranormal experiences and paranormal beliefs: A scoping review.
British Journal of Psychology, 2023, 114, 797-818, PMID: 37070349, FI: 3.2
Luque Del Moral R, Gastelurrutia MA, Martinez-Martinez F, ..., Fernandez-Gomez FJ*.
Effect of Pharmaceutical Intervention in Pharmacologically Treated Hypertensive Patients-A Cluster-Randomized Clinical Trial: AFPRES-CLM Study.
Journal of Personalized Medicine, 2023, 13, PMID: 37888095, FI: 3.0
Gisinger T, Azizi Z, Alipour P, ..., Herrero MT et al.
Sex and gender aspects in diabetes mellitus: Focus on access to health care and cardiovascular outcomes.
Frontiers in Public Health, 2023, 11, 1090541, PMID: 36817907, FI: 3.0
Cabrera-Maqueda JM, Boia R, Lucas-Ruiz F, ..., Agudo-Barriuso M*, Galindo-Romero C*.
Neuroinflammation and gliosis in the injured and contralateral retinas after unilateral optic nerve crush.
Experimental eye Research, 2023, 235, 109627, PMID: 37619829, FI: 3.0
De Araujo FM, Frota AF, de Jesus LB, Cuenca-Bermejo L et al.
Protective Effects of Flavonoid Rutin Against Aminochrome Neurotoxicity.
Neurotoxicity Research, 2023, 41, 224-241, PMID: 36723781, FI: 2.9
Marin JM, Hervella L, Villegas E et al.
Visual Performance at All Distances and Patient Satisfaction With a New Aspheric Inverted Meniscus Intraocular Lens.
Journal of Refractive Surgery, 2023, 39, 582-588, PMID: 37675912, FI: 2.9
Garcia-Carmona JA, Amores-Iniesta J, Soler-Usero J, ..., Almela P.
Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia.
Genes, 2023, 14, PMID: 37510225, FI: 2.8
Lopez-Gonzalez L, Martinez-de-la-Torre M, Puelles L*.
Populational heterogeneity and partial migratory origin of the ventromedial hypothalamic nucleus: genoarchitectonic analysis in the mouse.
Brain Structure & Function, 2023, 228, 537-576, PMID: 36598560, FI: 2.7
Malaguarnera M, Catania VE, Malaguarnera M et al.
Carnitine derivatives beyond fatigue: an update.
Current Opinion in Gastroenterology, 2023, 39, 125-128, PMID: 36821461, FI: 2.6
Popovic N, Morales-Delgado N, De la Cruz-Sanchez E, Popovic M.
Rats conserve passive avoidance retention level throughout the light phase of diurnal cycle.
Physiology & Behavior, 2023, 268, 114234, PMID: 37172638, FI: 2.4
Garcia-Carmona JA, Pappa S et al.
Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal.
, 2023, 15, 113-123, PMID: 37720806, FI: 1.6
Almela MT, Navarro-Zaragoza J, Laorden ML, ..., Almela P*.
Cut-off value for beta-trace protein (beta-TP) as a rapid diagnostic of cerebrospinal fluid (CSF) leak detection.
Laryngoscope Investigative Otolaryngology, 2023, 8, 1233-1239, PMID: 37899857, FI: 1.6
Galecio JS, Escudero E, Egas D et al.
Disposition kinetics of tildipirosin in alpacas after parenteral administrations
Small Ruminant Research, 2023, 229, PMID: null, FI: 1.6
Quesada Lopez M, Amaya Pascasio L, Blanco Madera S, ..., Garcia-Carmona JA et al.
External Validation of SAFE Score to Predict Atrial Fibrillation Diagnosis after Ischemic Stroke: A Retrospective Multicenter Study.
, 2023, 2023, 6655772, PMID: 38099264, FI: 1.5
Di Pierdomenico J*, Gonzalez-Gonzalez R, Valiente-Soriano FJ, ..., Garcia-Ayuso D*.
Attitudes and knowledge of myopia management by Spanish optometrists.
International Ophthalmology, 2023, 43, 4247-4261, PMID: 37596425, FI: 1.4
Galindo-Romero C, Rodriguez-Zamora CL, Garcia-Ayuso D, ..., Valiente-Soriano FJ*.
Computer vision syndrome-related symptoms in presbyopic computer workers.
International Ophthalmology, 2023, 43, 3237-3245, PMID: 37103757, FI: 1.4
Candeliere-Merlicco A, Villaverde-Gonzalez R, Hidalgo-Perez PV et al.
Dimethyl fumarate induced Wells syndrome. A case report.
Revista de Neurologia, 2023, 76, 337-339, PMID: 37165530, FI: 0.8
Galecio JS, Badillo E, Escudero E et al.
Antimicrobial Susceptibility of Pasteurella multocida Isolated from Sheep with Fibrinous Pneumonia
Acta Veterinaria-Beograd, 2023, 73, PMID: null, FI: 0.7
AYUDAS CONCEDIDAS EN 2023
TOTAL DE AYUDAS CONCEDIDAS
0
Nº Ayudas
0.0M €
Financiación
TOTAL DE AYUDAS RECURSOS HUMANOS CONCEDIDAS
0
Nº Ayudas
0.0M €
Financiación
TOTAL DE AYUDAS PROYECTOS I+D+i CONCEDIDAS
0
Nº Ayudas Europeas
0.0M €
Financiación Europea
0
Nº Ayudas Nacionales
0.0M €
Financiación Nacional
0
Nº Ayudas Regionales
0.0M €
Financiación Regional
TOTAL DE REDES CONCEDIDAS
0
Nº Ayudas
0.0M €
Financiación
OTRAS AYUDAS COMPETITIVAS CONCEDIDAS (MOVILIDAD, ORGANIZACIÓN DE EVENTOS CIENTÍFICOS, ...)
0
Nº Ayudas
0.0K €
Financiación
PROYECTOS DE I+D+i Y AYUDAS DE RRHH ACTIVAS EN 2023
12
TOTAL AYUDAS
1
RECURSOS HUMANOS
1
REDES
0
PROYECTOS INTERNACIONALES
6
PROYECTOS NACIONALES
4
PROYECTOS REGIONALES
INICIADA EN 2023
6
Nº Estudios
4
Nº Ensayos Clínicos
1
Nº Producto Sanitario
1
Nº Estudios Post-Autorización
0
Nº Otros Estudios
ACTIVOS EN 2023
53
Nº Estudios
27
Nº Ensayos Clínicos
8
Nº Producto Sanitario
12
Nº Estudios Post-Autorización
6
Nº Otros Estudios
FACTURACIÓN EN 2023
0.63M €
Facturado
6
Nº Tesis (0 con mención internacional)
Web desarrollada por la Plataforma de Informática Biomédica y Bioinformática